Journal article
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer
David S Binns, Andrea Pirzkall, Wei Yu, Jason Callahan, Linda Mileshkin, Peter Conti, Andrew M Scott, David Macfarlane, Bernard M Fine, Rodney J Hicks
European Journal of Nuclear Medicine and Molecular Imaging | SPRINGER | Published : 2011
Grants
Funding Acknowledgements
This work was supported financially by Genentech, Inc., South San Francisco, CA, USA. Drs. Pirzkall, Yu and Fine are employees at Genentech, Inc., and own stock with F. Hoffmann-La Roche, Ltd.